Monday, July 13, 2026

FDA Approves Adquey (difamilast 1%) Ointment for the Treatment of Mild-to-Moderate Atopic Dermatitis

›
Acrotech Biopharma Inc., a bio-pharmaceutical company focused on developing and commercializing innovative propriety medications, in collabo...
Saturday, July 11, 2026

FDA Approves Bysanti (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia

›
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved Bysanti (milsaperido...
Friday, July 10, 2026

Caffeine reversed memory problems caused by sleep deprivation

›
In continuation of my update on  Caffeine Researchers at the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Me...
Thursday, July 9, 2026

FDA Approves Desmoda (desmopressin acetate) Oral Solution for Central Diabetes Insipidus

›
In continuation of my update on  Desmoda Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical co...
Wednesday, July 8, 2026

FDA Grants Accelerated Approval to Yuviwel (navepegritide) for Children with Achondroplasia

›
Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has granted approval under the FDA’s A...
Tuesday, July 7, 2026

FDA Approves Icotyde (icotrokinra) for the Treatment of Plaque Psoriasis

›
Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved Icotyde (icotrokinra), an in...
Monday, July 6, 2026

FDA Approves Lynavoy (linerixibat) for Cholestatic Pruritus in Patients with Primary Biliary Cholangitis

›
GSK  announced   the US Food and Drug Administration (FDA)  approval of  Lynavoy (linerixibat) for the treatment of cholestatic pruritus in ...
Friday, July 3, 2026

FDA Approves Lifyorli (relacorilant) Plus Nab-Paclitaxel for the Treatment of Patients with Platinum-Resistant Ovarian Cancer

›
In continuation of my update on  relacorilant Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the di...
Thursday, July 2, 2026

How a cheap, century-old drug can improve life with type 1 diabetes

›
In continuation of my update on Metformin A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug red...
Wednesday, July 1, 2026

Synthetic stress hormone dexamethasone could reduce certain breast cancer metastases

›
The drug dexamethasone supplements cancer treatments to alleviate side effects of chemotherapy such as nausea or inflammation. Researchers a...
Tuesday, June 30, 2026

Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs

›
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmace...
Monday, June 29, 2026

Elevar Therapeutics Announces FDA Acceptance for Review of New Drug Application for Lirafugratinib as Second-line Cholangiocarcinoma Treatment

›
Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevat...
Saturday, June 27, 2026

How statins harm muscles—and how to stop it

›
In continuation of my update  on statin   Statins have transformed heart health, saving millions of lives by lowering cholesterol and reduci...
Thursday, June 25, 2026

Methamphetamine impairs dopamine uptake by targeting a protein modification

›
In continuation of my update on  Methamphetamine Dopamine brings on a surge of pleasure, but too much dopamine in a synapse can ultimately l...
Tuesday, June 23, 2026

Polyphenol-rich diets associated with lower long-term cardiovascular disease risk

›
In continuation of my update on  Polyphenol-rich diets  People who regularly consume polyphenol-rich foods and drinks, such as tea, coffee, ...